Skip to content

Mix and Match Study of Two Multifocal Intraocular Lens With Different Add Power

Mix and Match Study of Two Multifocal Intraocular Lens With Different Add Power

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02556944
Enrollment
40
Registered
2015-09-22
Start date
2015-04-30
Completion date
2016-04-30
Last updated
2015-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Presbyopia

Keywords

Depth of focus

Brief summary

To assess postsurgical visual acuity (distant, intermediate, near), refractive errors, contrast sensitivity, visual function and patient satisfaction after implantation of multifocal IOLs of different add power contralaterally.

Detailed description

Multifocal intraocular lens (MIOL) is considered a prevailing alternative to restore the functional vision from far to near independent of glasses. Many clinical studies on diffractive MIOLs, refractive MIOLs, or hybrid MIOLs in enhancing quality of vision showed promising outcomes. Several studies have confirmed the satisfactory visual outcomes of Tecnis MIOL with +4.00 D add power. The purpose of study is to assess the visual performance after cataract surgery with bilateral implantation of multifocal IOL with two different add power (+2.75 D or +3.25 D) in one patient.

Interventions

DEVICEPhacoemulsification with multifocal intraocular lens

Phacoemulsification and implantation of a multifocal intraocular lens (IOL) with two different add power (+2.75 diopters (D) or +3.25 D, respectively) in each eye of a patient, contralaterally. They're called mix and matched patients.

Sponsors

tae-young chung
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* • Age-related cataract * Adult at the age of 21 or older at the time of the pre-operative examination and willing to have surgery on their 2nd eye within 7-28 days of their 1st eye. * A patient has the visual potential of 20/25 or better in each eye after cataract removal and IOL implantation. * A patient with preoperative corneal astigmatism from IOL Master less than 1 diopters * Written informed consent to surgery and participation in the study

Exclusion criteria

* • Pregnant woman and lactating woman * A patient with history of retinal disease * A patient with history of ocular trauma or ocular surgery (Intraocular surgery, refractive surgery, ocular surface surgery) in either eye * A patient with evidence of keratoconus or significant irregular astigmatism on pre-operative topography in either eye. * A patient that has been wearing PMMA lenses within 6 months, gas permeable lenses within one month, or extended -wear or daily soft contact lens within 7 days of their scheduled surgery. * Those with other diseases that can affect capsule stability such as pseudoexoliation syndrome, glaucoma, traumatic cataract, or marfan syndrome * Those who are not able to read and understand the informed consent (illiterate or foreigners)

Design outcomes

Primary

MeasureTime frame
Visual acuity(Distant, intermediate, near)1month

Secondary

MeasureTime frame
Visual acuity(Distant, intermediate, near)3month

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026